Biologics for Stricturing Crohn's Diseases

Jinling Hospital, China

Status: Enrolling

Conditions: The Efficacy of Biologics for Stricturing Crohn's Diseases

Treatments: Other: treat these patients with biologics

Study type: Observational

Funder types: Other

Identifiers

NCT05645055

JinlingH20221203

Details and patient eligibility

About

Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases.

Enrollment: 200 estimated patients

Sex: All

Ages: 16 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with stricturing Crohn's diseases
• no surgical indication
• patients with asymptomatic penetrating diseases
• written consent acquired

Exclusion criteria

• patients with surgical indication
• patients with symptomatic penetrating diseases
• contraindication of biologics
• anticipating other trial

Trial design

200 participants in 1 patient group

Patients with stricturing Crohn's diseases

Description:

Patients with stricturing Crohn's diseases

Treatment:

Other: treat these patients with biologics